Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace Directory

Xpert HBV Viral Load gets CE-IVD mark

May 2019—Cepheid announced the CE-IVD marking of Xpert HBV Viral Load, a rapid test for the quantitation of hepatitis B virus that delivers results in less than one hour.

Liquid biopsy workflows for cancer research

May 2019—Qiagen introduced its exoRNeasy Midi and Maxi kits for isolation of exosomes and other extracellular vesicles from urine and other samples and its miRNeasy 96 Advanced QIAcube HT Kit for automated purification of total RNA, including miRNA, from serum and plasma samples.

Binding Site expands line of antibodies, antigens

May 2019—Binding Site’s Immunologicals Group has added purified monoclonal antibodies for the testing of human immunodeficiency virus, designed for use as components within enzyme immunoassay test procedures.

Sysmex America launches UN-2000

May 2018—Sysmex America announced the availability of its first fully automated urine particle counter and digital imaging system, the UN-2000. The scalable system is composed of the UF-5000 automated urine particle analyzer and UD-10 automated urine particle digital imaging device.

Nikon unveils digital pathology solution

May 2019—Nikon Instruments debuted the OS-15-N, a digital slide scanning system featuring Nikon optics, at the USCAP annual meeting, March 16–21, National Harbor, Md. Nikon partnered with OptraScan to provide an end-to-end digital pathology solution that takes advantage of Nikon’s optics and OptraScan’s desktop slide scanning system, the OS-15.

FDA expands pembrolizumab indication for NSCLC

May 2019—The Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with stage III non-small cell lung cancer who are not candidates for surgical resection or definitive chemoradiation or metastatic NSCLC.